Saurabh Joshi Shripad

Saurabh Joshi Shripad is director of solutions engineering at ValGenesis Inc. He is on a mission to help life sciences companies build a robust digital road map. For more than two decades, he led quality in operations, qualifications/validations, QMS, centers of excellence, and consulting. Shripad has a bachelor’s degree in pharmacy, has worked with renowned pharmaceutical companies such as Cipla, Microlabs Ltd., Wockhardt India/EU, and Sun Pharma, and has partaken in many USFDA, MHRA, HPRA/IMB, and WHO regulatory inspections. As a domain expert, he advises life sciences companies on appropriate digital solutions to help resolve their underlying problems. He firmly believes that going digital will help organizations become more resilient and sustainable.

Thu, 04/11/2024 - 12:02
Enhancing Cleaning Validation for Established Pharma OperationsDigital transformation can reduce errors and simplify compliance
Wed, 03/12/2025 - 12:02
Established pharmaceutical facilities play a pivotal role in public health by ensuring the safety and efficacy of the medications they produce. This critical responsibility demands strict adherence to the Code of Federal Regulations, including 21…
AI-Powered Risk Assessment Revolutionizes Pharma Product DevelopmentImproves efficiency, accuracy, and reliability of preventive assessments
Mon, 09/23/2024 - 12:03
Before the ICH Harmonized Tripartite Guideline Q9—“Quality risk management”—was introduced in 2005, the pharmaceutical industry was evolving but lacked a structured, scientific, and systematic approach. Various stakeholders, including the industry,…
Integrating Risk Assessment and Continual Process VerificationInvesting in technology to integrate quality will improve efficiency and competitiveness
Thu, 04/11/2024 - 12:02
Risk assessment and continual process verification (CPV) are fundamental regulatory requirements for pharmaceutical companies to ensure drug safety, efficacy, and quality. While risk assessment involves analyzing, mitigating, communicating, and…